Alcan and Kaiser Aluminum To Continue Trade Agreement

Alcan Inc. has announced that the 300,000 tonne per year alumina supply agreement between Kaiser Aluminum International. and its subsidiary Pechiney Trading Company remains valid and enforceable for its entire duration until the end of 2006.

The motion filed against PTC by Kaiser Aluminum Corporation and affiliated entities (including Kaiser Aluminum & Chemical Corporation (KACC) and KAII) to cancel the alumina supply agreement in connection with KACC's proposed sale of its interest in the Alpart alumina refinery has been definitively withdrawn. The motion was filed on January 20, 2004 before the U.S. Bankruptcy Court for the District of Delaware, seeking to reject the five- year alumina supply agreement between KAII and PTC.

For more information on alumina

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kaiser Aluminum. (2019, March 19). Alcan and Kaiser Aluminum To Continue Trade Agreement. AZoM. Retrieved on April 23, 2024 from https://www.azom.com/news.aspx?newsID=1156.

  • MLA

    Kaiser Aluminum. "Alcan and Kaiser Aluminum To Continue Trade Agreement". AZoM. 23 April 2024. <https://www.azom.com/news.aspx?newsID=1156>.

  • Chicago

    Kaiser Aluminum. "Alcan and Kaiser Aluminum To Continue Trade Agreement". AZoM. https://www.azom.com/news.aspx?newsID=1156. (accessed April 23, 2024).

  • Harvard

    Kaiser Aluminum. 2019. Alcan and Kaiser Aluminum To Continue Trade Agreement. AZoM, viewed 23 April 2024, https://www.azom.com/news.aspx?newsID=1156.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.